Esmolol Hydrochloride
Sponsors
Novalead Pharma Private Limited, AOP Orphan Pharmaceuticals AG, Istanbul University, Beni-Suef University, Aretaieion University Hospital
Conditions
AnalgesiaAnesthesiaCerebral HemodynamicsCerebral Oxygen SaturationCognitive DysfunctionDexmedetomidineDiabetic Foot UlcerEsmolol
Phase 1
Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
CompletedNCT01113515
Start: 2014-02-20End: 2015-10-17Updated: 2024-05-20
A Pharmacokinetic, Pharmacodynamic, Safety Study With AOP LDLA202, ONO LDL50 and Esmolol in Healthy Volunteers
CompletedNCT01652898
Start: 2012-07-31End: 2012-08-31Updated: 2012-09-05
Dexmedetomidine and Esmolol Early Post Operative Cognitive Dysfunction
NCT03892512
Start: 2019-04-30End: 2019-12-31Target: 58Updated: 2019-03-27
Phase 3
Phase 4
Effect of Controlled Hypotension on Cerebral Oxygen Saturation
CompletedNCT02967029
Start: 2016-11-01End: 2017-08-01Updated: 2021-09-01
Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.
RecruitingNCT06291363
Start: 2024-04-16End: 2025-03-04Target: 64Updated: 2024-07-16
Unknown Phase
The Impact of Esmolol Administration on Postoperative Recovery
NCT05567822
Start: 2022-10-01End: 2024-10-01Target: 70Updated: 2022-10-27
Effect of Dexmedetomidine vs Esmolol or Placebo on Cerebral Hemodynamics in Septic Shock
CompletedNCT06169475
Start: 2020-11-01End: 2023-11-01Updated: 2023-12-13
Esmolol Versus Dexmedetomidine for Opioid-sparing in Laparoscopic Gynecological Surgery
RecruitingNCT07846722
Start: 2026-07-15End: 2027-02-01Target: 90Updated: 2026-09-29